Nangona isifo sesisu sesifo (IBD) sisigxina sezilwanyana ezinokubangela ukuba kunzima ukuxilonga nokuphatha, abaphandi baqokelelele ubungakanani obuninzi beenkcukacha ngokuphathelene nokuveliswa kwemfuza, ukusabalalisa, kunye negalelo lokusingqongileyo kwi-IBD. Ngokubanzi, i-IBD isifo sabamhlophe abahlala kumazwe athuthukile kwaye bavame ukufunyaniswa ngokuqhelekileyo kwiintsholongwane kunye nabantu abadala.
Nangona isifo sikaCrohn kunye nesifo sezilonda zesilonda sibonakala sisebenza kwiintsapho, ukuxhamla akusoloko kuthathe ngqo (njengomzali kumntwana). Umngcipheko wokuba uzuze i-IBD ngokuqhelekileyo iphantsi, ngaphandle kwimeko apho bobabili abazali banesimo se-IBD.
Ubudala be-IBD bubuninzi kakhulu
I-IBD idlalwa njengesifo sabantwana abaselula kunye nabaselula kuba okokuqala kuvunyelwene kubantu abaphakathi kweminyaka eyi-15 neye-25 (ubuncinci omnye umthombo ubonisa ukuba i-incidental incidence iphakathi kweminyaka eyi-15 ukuya kwe-35). Kubantu abayizigidi eziyi-1.6 e-United States abane-IBD, i-10% yabantwana. Kule minyaka engama-50 kukho enye inyuselo kwi-IBD.
Okuqhelekileyo Kwamadoda Nabafazi?
IBD ibonakala ichaphazela amadoda namabhinqa ngamanani alinganayo.
Ii-Geographic Areas IBD Ininzi kakhulu
I-IBD iqheleke kakhulu kwi:
- Amazwe athuthukileyo
- Iindawo zasemaphandleni
- Kwiindawo zeMntla
I-colcertic colitis ixhaphake kakhulu eUnited States nakumazwe aseNtla yaseYurophu kunye nomncinci oqhelekileyo eJapan naseMzantsi Afrika.
Bangaphi abantu ababenayo i-IBD?
Kuqikelelwa ngokubanzi ukuba abantu abayi-1.6 yezigidi e-United States bane-IBD. (Ezinye iingcali zibonisa ukuba le nombolo ingaba yinto esondeleyo.) EYurophu, inani labantu abane-IBD liqikelelwa li-2.2 yezigidi.
E-United States, ukusabalalisa kwe-IBD kukuba:
- Ulwelative colitis: abantu abayi-100 ukuya kuma-200 ngabantu abayi-100,000
- Isifo sikaCrohn: abantu abayi-30 ukuya kwi-100 kubantu abayi-1000,000
Izizwe kwiNgcipheko ePhakamileyo
- AmaYuda ase-Ashkenazi akwazi ukuphuhlisa i-IBD.
- I-IBD ixhaphake kakhulu kubantu abamhlophe kunye nabase-Afrika baseMerika, kwaye ubuncinci baqhelekileyo kubantu baseSpeyin naseAsia.
Izinto ezingqongileyo zengozi yokuphuhlisa i-IBD
Imiba emibini, i- appendectomy kunye nembali yokubhema i-cigarette , iboniswe ukuba inefuthe ekuphuhlisweni kwe-IBD. Iziphumo zezifundo ezili-13 ezenziwa phakathi kuka-1987 no-1999 zibonisa ukuba ukususwa kwesihlomelo kunganciphisa umngcipheko wokuvelisa i-ulcerative colitis ngamaphesenti angama-69.
Abokutshaya bade babesengozini enkulu yokuphuhlisa i-ulcerative colitis, ngelixa ababhemayo banomngcipheko omncinci. Olu tyekelo lubonisa ukuba ukutshaya umsila kukunceda ukukhusela ukuqala kwesilonda esiswini. Ukubhema i-cigarettes ngokwenene kunefuthe eliphambili kwisifo sikaCrohn; abantu ababhemayo, okanye abaye bavutha kwixesha elidlulileyo, banomngcipheko ophezulu wokuhlaselwa kwesifo sikaCrohn kunokuba abangabhemi.
Ubani Ubungozi Bokufa I-IBD?
- Kubonakala kubonakala kunomngcipheko oqaqambileyo wokufumana isifo seCrohn kune-ulcerative colitis, ngakumbi kwiintsapho zamaYuda.
- Abantwana abanomzali omnye kunye nesifo sikaCrohn bane-7 ukuya kwi-9% yobungozi bokuphila kwimeko kunye nenengozi ye-10% yokuphuhlisa uhlobo oluthile lwe-IBD.
- Abantwana babazali ababini abane-IBD banomngcipheko wama-35% wokuphuhlisa uhlobo lwe-IBD.
- Phantse i-20% yabantu abane-IBD banamalungu entsapho kunye ne-IBD.
- Umngcipheko we-IBD kubantu abanelungu lentsapho eline-IBD liphindwe ngamaxesha angaphezu kwe-10 kunabantu abonke.
- Umngcipheko we-IBD kubantu abanomntakwabo ophethe i-IBD ungama-30 aphezulu ngaphezu kwabantu kubonke.
Ezinye izinto, ezifana nokutya, ukusetyenziswa kwemithi yokukhulelwa komlomo , kunye nokusuleleka kwezifo zifundwa, kodwa indima yabo ayisacacanga.
Imithombo:
I-Crohn's neColitis Foundation yaseMelika. "Nge-Epidemiology ye-IBD." CCFA.org 1 Juni 2012. 28 Disemba 2013.
ULoftus EV Jr. "I-epidemiology ye-clinical of disease inflammatory disease: Ingozi, ukusabalalisa, kunye nefuthe lokusingqongileyo." Gastroenterology . 2004 ngoMeyi; 126 (6): 1504-17. 28 Disemba 2013.
Peeters M, Nevens H, Baert F, et al. "Ulwalamano oluqhelekileyo kwisifo sikaCrohn: Ukwanda kwexesha, ukulungelelaniswa kwengozi, kunye nokuvumelanisa kwiimpawu zeklinikhi." Gastroenterology . 1996; 111: 597-603. 28 Disemba 2013.